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AbsTrACT
Objective We aimed to explore whether age, period 
or cohort effects explain the trends and inequalities 
in ischaemic heart disease (ihD) and cerebrovascular 
disease (ceVD) mortality in scotland.
Methods We analysed ihD and ceVD deaths for 
1974–2015 by sex, age and area deprivation, visually 
explored the data using heatmaps and dotplots and built 
regression models.
results ceVD mortality improved steadily over time 
while ihD mortality improved more rapidly from the late 
1980s. age effects were evident; both outcomes showed 
an exponential relationship with age for all except males 
for ihD in the 1980s and 1990s. The mortality profiles by 
age became older, although improvement was slower for 
those aged <50 years for ihD, especially for males, and 
faster for ceVD in females aged <65 years. rates were 
higher, and inequalities greater, among males, especially 
for ihD. For ihD, increased risk for males over females 
reduced with age (incidence rate ratio for 41–50 year 
old males=4.28 (95% ci 4.12 to 4.44) and 1.17 (95% 
ci 1.16 to 1.18) for 71–80 year olds). inequalities in 
ihD mortality by area deprivation persisted over time, 
increasing from around 10% to around 25% higher risk 
in the most deprived areas between 1974 and 1986 
before declining in absolute terms from around 2000. 
inequalities for ceVD increased after the late 1980s.
Conclusions ihD and ceVD mortality in scotland 
exhibit age but not recent distinct period or cohort 
effects. The improvements in mortality rates have been 
more sustained for ceVD and inequalities greater for 
ihD.
InTrOduCTIOn
Ischaemic heart disease (IHD) and cerebrovascular 
disease (CeVD) have among the highest cause-spe-
cific mortality rates in Scotland and substan-
tially contribute to Scotland’s burden of disease.1 
Mortality rates for IHD have, however, been rapidly 
and consistently declining for both males and 
females aged 15–74 years of age since the 1980s, 
and for CeVD for the last 60 years.2 The relative 
decline in the rates of death has been greater for 
females than males between 1980–1982 and 2016.3 
Both IHD and CeVD mortality display marked 
inequalities by deprivation, with higher rates with 
increasing area deprivation.4 5 While mortality 
rates have fallen across the deprivation spectrum 
recently for both, IHD rates have decreased more 
in the most deprived areas reducing the absolute 
inequalities. However, in relative terms inequalities 
in IHD and CeVD have continued to increase.6
High levels of mortality from IHD, CeVD 
and cancer throughout adulthood together with 
increased mortality from alcohol-related and 
drug-related deaths, suicide and violence explain 
Scotland’s ‘excess’ mortality (ie, over and above 
that explained by deprivation) compared with 
England & Wales (E&W).7 These health outcomes 
have also contributed to Scotland’s slower improve-
ment in mortality and greater health inequalities 
compared with the rest of Western Europe.8–10 A 
greater vulnerability to economic and social changes 
resulting from political changes of the 1980s has 
been proposed to best explain these mortality 
trends.7
Using age, period, cohort (APC) analyses we have 
shown that age-period effects help explain recent 
trends in alcohol-related deaths11 and that cohort 
effects explain trends in suicide and drug-related 
deaths, especially among young males in deprived 
areas.12 13 These effects are consistent with the 
proposed hypothesis to explain Scotland’s ‘excess' 
mortality. Given the importance of IHD and CeVD 
in the relatively high mortality rates in Scotland we 
wanted to explore whether there is also evidence 
for APC effects for these causes in the overall Scot-
tish trends that could correspond to the changing 
political context from the 1980s and whether 
APC effects might explain some of their inequality 
trends.
MeThOds
data sources
Data on the number of deaths due to IHD and 
CeVD by sex, single year of age at death and year 
of registration of death for Scotland from 1974 to 
2015, and mid-year population estimates for Scot-
land by sex and single year of age, from age 0 to 89 
years (with pooled data for ages 90+), from 1974 
to 2015, were obtained from the National Records 
of Scotland (NRS). IHD deaths (n=5 97 850) from 
1974 to 1978 were coded by International Classi-
fication of Diseases 8 (ICD8) 410–414, from 1979 
to 1999 by ICD9 410–414, and from 2000 onward 
by ICD10 I20–25. CeVD deaths (n=3 05 542) from 
1974 to 1978 were coded by ICD8 430–438, from 
1979 to 1999 by ICD9 430–438 and from 2000 
onward by ICD10 I60–69 and G45.
Analyses by deprivation were based on Carstairs 
area deprivation scores14 which are available 
around each census year (1981 and every 10 years 
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Figure 1 Heatmap plot of log (base10) age–year specific crude 
mortality rates per 100 000 population in Scotland for each single age 
from 15 to 89 years and each year from 1974 to 2015 stratified by sex 
for IHD and CeVD. CeVD, cerebrovascular disease; IHD, ischaemic heart 
disease.
thereafter). Carstairs look-up files were obtained from Infor-
mation Services Division Scotland (ISD) and each death was 
assigned to a deprivation category using the nearest census. 
Deaths with missing deprivation data (2.8% and 2.3% of IHD 
and CeVD datasets respectively) were removed from depriva-
tion analyses. Population data by Carstairs, from age 0 to 84 
years (with pooled data for ages 85+), were obtained from ISD 
with interpolation between the censuses. IHD and CeVD cases 
are rare in those aged <15 years, and the denominator popula-
tions were less certain for those aged 90+ years so, unless stated 
otherwise, analyses were restricted to those aged 15–89 years, 
or aged 15–84 years for deprivation analysis. Data manipulation 
was performed using IBM SPSS Statistics V.19 and Microsoft 
Excel 2013.
descriptive analysis
For trend analysis, death rates for all ages from 1974 to 2015 by 
sex were age-standardised using direct age standardisation and 
the 2013 version of the European Standard Population as the 
standard population. For age effects analysis, data from 1974 to 
1994 and data from 1995 to 2015 were separately combined for 
presentation of crude death rates by 5-year age groups (from 0-4 
years to 90+ years (85+ years for deprivation analysis) for age 
at death by sex.
Two methods were used to support visual exploration of how 
cause-specific mortality rates have changed at different ages 
and over time: heatmaps of rates by age and year; and coloured 
dotplots plotting rates against age for each of the years. These 
were produced in R. For the heatmaps (Lexis surfaces)15 one 
axis was single year of age and the other single year of death 
(see appendix 1 in Parkinson et al12). The colours of the squares 
making up the heatmap were determined by the size of the 
(base10) logarithm of the mortality rate for each specific combi-
nation of age and year; squares of the same colour indicate the 
same mortality rates. The coloured dotplots show mortality rate 
for a single age and year of death on the vertical axis (with a log10 
scale) against age on the horizontal axis; the colours of dots indi-
cate the year of death. A continuity correction of 0.5 was added 
to both the numerator and denominator before rates based on 
five or fewer observations were excluded due to unreliability.
We undertook an initial analysis by deprivation comparing 
areas ranked by deprivation quintiles and thereafter, for ease of 
presentation and unless noted otherwise, compared areas ranked 
in the 40% most deprived areas to the 40% least deprived areas.
statistical analysis
Visual exploration of the data revealed a relatively contin-
uous trend in age-specific mortality improvement for CeVD, a 
more discontinuous trend for IHD, and some sex and depriva-
tion group differences. Intrinsic estimator models using the IE 
command in Stata (as described in Parkinson et al12 13 and online 
supplementary appendix 1) were used to explore whether any 
clear APC effects were evident and did not identify any clear 
effects other than age effect (online supplementary appendix 1). 
Multivariable binomial regression models were therefore used to 
model these patterns and control for sex and deprivation (online 
supplementary appendix 2). The Carstairs deprivation variable 
was categorised as the most deprived 40%, central 20% and least 
deprived 40% of areas. The command margins, predict (ir) in 
Stata V.14.2 was used to provide predictions for the mortality 
rate assuming all other independent variables were at mean 
values. This provides a measure of difference (with a p value) 
for a variable such as sex, which takes into account the variable’s 
interaction with other variables. Predicted rates (based on the 
fully-adjusted models in online supplementary appendix 2) also 
take into account interactions between the variables and supple-
ment descriptive analyses.
Patient and public involvement statement
Neither patients nor the public were involved in the design, or 
conduct, or reporting, or dissemination of our research.
resulTs
Age-period-cohort analysis
IHD and CeVD mortality rates differ by age, an age effect, 
with very few deaths occurring among those aged <40 years in 
both sexes for CeVD and for females for IHD and among those 
aged <30 years for males for IHD (figure 1). Above these ages 
mortality rates increase broadly exponentially with age, for all 
except males for IHD in the 1980s/‘90s (discussed below), seen 
as ‘diagonal straight lines’ for any given year in the coloured 
dotplots (figure 2).
There is a known cohort effect for those born around 
1918, especially for IHD (online supplementary figure 1).15 
The absence of other vertical patterns and diagonal ‘disrup-
tions’ running from bottom left to top right in figure 1 indi-
cate that simple cohort and period effects do not explain the 
trends observed. Confirmed by the Intrinsic Estimator models 
which only identified clear age effects (online supplementary 
appendix 1).
copyright.
 o
n
 Septem
ber 24, 2019 at University of G
lasgow. Protected by
http://heart.bmj.com/
H
eart: first published as 10.1136/heartjnl-2019-315029 on 20 September 2019. Downloaded from 
3Parkinson J, et al. Heart 2019;0:1–6. doi:10.1136/heartjnl-2019-315029
Cardiac risk factors and prevention
Figure 2 Coloured dotplot of mortality rate per 100 000 population 
in Scotland by age for those aged 30 to 89 years, from 1974 to 2015, 
stratified by sex for IHD and CeVD. CeVD, cerebrovascular disease; IHD, 
ischaemic heart disease.
Figure 3 European age-standardised IHD and CeVD rate per 100 
000 population per year in Scotland 1974–2015, by sex. CeVD, 
cerebrovascular disease; IHD, ischaemic heart disease.
Table 1 Gap in mortality rates by sex for different age groups for 
IHD and CeVD, 1974–2015
Age group (years)
Ihd incidence rate ratio:
95% CI (p value)
CeVd incidence rate ratio:
95% CI (p value)
40 and under Not estimable 1.06: 0.98 to 1.16 (p=0.14)
41–50 4.28: 4.12 to 4.44 (p<0.001) 0.97: 0.92 to 1.03 (p=0.36)
51–60 3.15: 3.08 to 3.21 (p<0.001) 1.14: 1.10 to 1.18 (p<0.001)
61–70 1.98: 1.95 to 2.00 (p<0.001) 1.13: 1.11 to 1.15 (p<0.001)
71–80 1.17: 1.16 to 1.18 (p<0.001) 0.79: 0.78 to 0.80 (p<0.001)
81+ Not estimable Not estimable
Female is the reference category so an incidence rate ratio >1 indicates a greater 
rate for males.
CeVD, cerebrovascular disease; IHD, ischaemic heart disease.
Trends in mortality by age
The age profiles of death from IHD and CeVD have become 
older over the period for both sexes (figure 1 and online supple-
mentary figure 2), evidenced in the coloured dotplot by the dots 
for more recent years tending to be below those for the same 
age in previous years, as the mortality risks at specific ages have 
decreased (figure 2 and supplementary file video 1). The statis-
tical modelling confirms these observations (online supplemen-
tary figure 3).
There are important differences between IHD and CeVD 
trends. First, there was only modest improvement in age-spe-
cific mortality until the end of the 1980s for IHD, with faster 
improvement thereafter, contrasting with more continuous 
improvement for CeVD. Second, the relationship between age 
and mortality was not exponential for males for IHD in the 1980s 
and 1990s, with rates increasing faster per year of age between 
those aged around 30–50 years than at older ages (figure 2 and 
supplementary file video 1). IHD mortality improvement was 
also slower for those aged around 50 years and under, espe-
cially for males (figures 1 and 2). In comparison, improvement 
in CeVD mortality rates was similar for all ages except females 
aged <65 years where improvement was slightly faster.
The fully adjusted statistical models showed that the discon-
tinuity in the IHD mortality trends is starkest at older ages 
and is more continuous at younger ages (online supplementary 
figure 4).
Trends in mortality by sex
Age-standardised rates for both IHD and CeVD mortality 
have declined for both males and females over the time period 
(figure 3). Rates of IHD in 1974 were higher for males than 
females but have fallen faster for males, especially since around 
1987. By 2015 the gap in rates between the sexes was much 
reduced. In contrast, the difference in CeVD rates between the 
sexes in 1974 was considerably smaller and had almost disap-
peared by the late-2000s. Higher mortality rates for males are 
evident at all ages and time periods for both IHD and CeVD 
(figure 1), although this sex difference is less noticeable for 
CeVD. The pattern of improvement over time has largely been 
similar for both males and females for CeVD but differs for IHD 
for younger adults.
The fully adjusted statistical models (online supplementary 
appendix 2) confirm the larger gap between male and female 
mortality rates for IHD compared with those for CeVD, which 
is more evident at older ages (online supplementary figure 4). 
For both IHD and CeVD, the gap between males and females has 
reduced in all age groups above 40 years over the period, largely 
due to faster improvements among males.
Results from margins analysis over the full period confirms a 
higher risk for males for IHD in every age group where a result 
was estimable (table 1), with the increased risk for males over 
females reducing in each subsequent age group. For CeVD, the 
differences between the age groups are smaller with no evidence 
of a difference in risk in the 41–50 years group and females 
having higher risks in the 71–80 years group.
Trends in mortality by area deprivation
Inequalities in age-standardised IHD mortality rates by area 
deprivation are evident for the whole time series and are greater 
among males in absolute terms (figure 4, online supplementary 
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Figure 4 European age-standardised IHD and CeVD rate per 100 000 
population per year in Scotland, 1974–2015, by sex and deprivation. 
CeVD, cerebrovascular disease; IHD, ischaemic heart disease.
Figure 5 Heatmap plot of log (base10) age–year specific crude 
mortality rates per 100 000 population in Scotland for each single age 
from 15 to 84 years and each year from 1974 to 2015 stratified by sex 
and deprivation for IHD and CeVD. CeVD, cerebrovascular disease; IHD, 
ischaemic heart disease.
Figure 6 Coloured dotplot of mortality rate per 100 000 population 
in Scotland by age for those aged 30 to 84 years, from 1974 to 
2015, stratified by sex and deprivation for IHD and CeVD. CeVD, 
cerebrovascular disease; IHD, ischaemic heart disease.
Table 2 Gap in mortality rates between most deprived and least 
deprived 40% of areas for IHD and CeVD at different time points
Ihd incidence rate ratio: 
95% CI (p value)
CeVd incidence rate ratio: 
95% CI (p value)
Males—1974 0.90: 0.85 to 0.94 (p<0.001) 1.01: 0.89 to 1.14 (p=0.897)
Males—1986 0.75: 0.71 to 0.80 (p<0.001) 0.84: 0.74 to 0.96 (p=0.009)
Males—2015 0.74: 0.69 to 0.81 (p<0.001) 0.81: 0.71 to 0.94 (p=0.004)
Males—Full period 0.81: 0.80 to 0.82 (p<0.001) 0.90: 0.88 to 0.92 (p<0.001)
Females—1974 0.91: 0.85 to 0.97 (p=0.003) 0.96: 0.86 to 1.07 (p=0.459)
Females—1986 0.73: 0.68 to 0.79 (p<0.001) 0.77: 0.69 to 0.87 (p<0.001)
Females—2015 0.73: 0.65 to 0.81 (p<0.001) 0.93: 0.81 to 1.06 (p=0.264)
Females—Full period 0.77: 0.76 to 0.78 (p<0.001) 0.92: 0.90 to 0.94 (p<0.001)
The reference category is most deprived so an incidence rate ratio <1 indicates a 
reduced risk for least deprived.
CeVD, cerebrovascular disease; IHD, ischaemic heart disease.
figure 5 and relative index of inequality (RII) and slope index 
of inequality (SII) analysis in online supplementary appendix 
3). Inequalities increased in the late 1980s because of a faster 
improvement in the least deprived areas. Since around 2000 the 
rate of improvement has been greater in the most deprived areas, 
reducing the absolute inequalities across the population.
In contrast, CeVD rates were more similar in the most and 
least deprived areas and declined at similar rates from 1974 
to the mid-1980s but inequalities emerged in the late 1980s 
(figure 4, online supplementary figure 5 and RII and SII analysis 
in online supplementary appendix 3). This absolute inequality 
has remained for males but narrowed among females.
There are also clear differences in the age profiles of mortality 
from IHD for males and females by area deprivation and over 
time (figure 5 and online supplementary figure 6). Rates of death 
are consistently higher at all ages and improved later for those 
living in more deprived areas. The slower rate of improvement 
in IHD mortality for those aged around <50 years and under is 
more evident for those in more deprived areas while the faster 
improvement in CeVD rates for females aged <65 years is more 
evident in less deprived areas. The dotplots of log mortality 
rates by age for the period confirm the inequalities in mortality, 
especially for IHD and for males (figure 6 and supplementary 
files videos 2 and 3).
The fully adjusted statistical models (online supplementary 
appendix 2) confirm the inequalities in mortality rates, with 
higher rates for those living in the two most deprived quintile 
areas for both IHD and CeVD and males and females (online 
supplementary figure 7). Margins analysis suggest that for IHD 
there are inequalities for both males and females throughout the 
period; increasing from around 10% in 1974 to around 25% 
by 1986 and remaining at this level through to 2015 (table 2). 
The corresponding data for CeVD suggest that there was no 
inequality in 1974 but by 1986 the inequality was 23% for 
females and 16% for males. By 2015 the gap was no longer 
significant for females but had increased to 19% for males.
dIsCussIOn
Main results
No noticeable recent period or cohort effects were identified to 
explain the trends in mortality for either outcome, but there was 
evidence of an exponential relationship with age for all except 
males for IHD in the 1980s/‘90s. The age profiles for death have 
become older, although the rate of improvement was slower for 
those aged around 50 years and under, especially for males, for 
IHD and slightly faster for females aged <65 years for CeVD.
While mortality rates of both IHD and CeVD fell between 
1974 and 2015, CeVD mortality improved steadily while IHD 
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Key questions
What is already known on this subject?
 ► Ischaemic heart disease (IHD) and cerebrovascular disease 
(CeVD) have among the highest cause-specific mortality rates 
in Scotland. They are causes of death partly responsible for 
‘excess' mortality in Scotland (the higher mortality compared 
to England & Wales after accounting for deprivation). 
Mortality rates for both have been declining in Scotland for 
over 35 years.
What might this study add?
 ► CeVD mortality has improved steadily at most ages from 
1974 to 2015, while improvements in age-specific IHD 
mortality have been much faster from the late 1980s, a 
discontinuity starkest at older ages. Inequalities by area 
deprivation in mortality from IHD widened between the 
late 1980s and 2000 before reducing in absolute terms; 
inequalities by area deprivation in CeVD mortality appeared 
from the late 1980s onwards.
 ► There are no recent distinct period or cohort effects for 
IHD and CeVD mortality trends in Scotland, but there is an 
exponential relationship with age for both causes for all 
except males for IHD in the 1980s and 1990s.
 ► This contrasts to suicide and drug-related, and alcohol-
related deaths that also contribute to Scotland’s 'excess' 
mortality and for which cohort effects and age-period effects, 
respectively, help explain their recent trends.
how might this impact on clinical practice?
 ► It is important for clinical practice that there is an 
understanding of how trends in mortality by IHD and CeVD 
have changed over time by age, sex and deprivation. This 
shows that more work is required to reduce inequalities in 
these outcomes.
mortality improved more rapidly from the late 1980s. Rates 
decreased faster for males than females such that by 2015 the gap 
between the sexes for IHD was greatly reduced and had almost 
disappeared for CeVD. Inequalities in mortality by area depri-
vation were evident for IHD, especially for males, increasing 
in the late 1980s and then subsequently decreasing in absolute 
terms and were larger than those for CeVD. For CeVD, inequal-
ities only became apparent from the late 1980s. This absolute 
inequality has remained for males.
Despite no evidence for simple period or cohort effects for 
both IHD and CeVD mortality, the more rapid secular improve-
ment in mortality rates at older ages for IHD could be interpreted 
as a period-cohort interaction which reduced the mortality rates 
for each subsequent birth cohort. This appears to have started 
around 1985 when rates of IHD deaths improved more rapidly 
for older birth cohorts (older ages) who retained this higher 
rate of improvement while improvement remained slower for 
younger adults. It is not possible to determine which of the many 
possible factors could have disproportionately impacted those in 
the older age groups to explain this period-cohort effect.
strengths and weaknesses of the analysis
This study used a complete record of all deaths in Scotland over 
the time period and there are sufficient numbers of deaths to 
show the patterning of mortality over time and by age, and 
allowed for more detailed inequalities analysis. It was not 
possible to analyse trends pre-1974 as individual digital records 
were only introduced by NRS in 1974. Our analysis is based 
on the year that a death was registered rather than the year of 
occurrence, to match the NRS coding convention, so the data for 
any single year may differ slightly from that for the actual date of 
events. We present most of our deprivation analysis comparing 
the most and least deprived 40% of areas. Our sensitivity anal-
ysis shows that while the 40–40 comparison will inevitably show 
smaller differences between groups, especially for IHD, the 
overall conclusions are the same (figure 4 and online supple-
mentary figure 5). Subsequent to our analysis, a revision was 
made by NRS to their Scottish mid-year population estimates for 
2002–2010, which affected the age distribution for those aged 
81 years and above (see https://www. nrscotland. gov. uk/ files// 
statistics/ population- estimates/ mid- year- corrections/ correction- 
to- age- distribution- mid- year- pop- estimates- 2002- 2010. pdf). 
Sensitivity analysis showed that this had no effect on our results.
Comparison with other studies
The absence of distinct recent cohort and period effects for IHD 
and CeVD contrasts with our findings from APC analysis for 
suicide and drug-related deaths, and for alcohol-related deaths 
in Scotland, respectively.11–13 This may be due to longer lag 
effects for IHD and CeVD which obscure real effects, or due to 
different causal pathways driving those trends.
Our results are consistent with and expand those found by 
others for IHD and CeVD mortality in Scotland showing age, 
sex and area deprivation inequalities.4 5 Previous analysis of IHD 
mortality in Scotland from 1986 to 2006 also noted that reduc-
tions in mortality rates have levelled off for young adults (aged 
35–54 years) since 1996, especially for males and in the most 
deprived areas.16 A trend in IHD rates for young adults reported 
in several countries including E&W.17 Studies using slightly more 
contemporary data have highlighted that the recent slowing in 
all-cause mortality rates across Britain may be partially due to 
a reduction in the rate of improvement in IHD (Fenton et al, 
2019, personal communication).
The reductions in mortality are attributed to both reduced 
incidence and case fatality rates. This is credited to (i) improve-
ment in primary prevention strategies such as pharmacological 
management of risk factors such as hypercholesterolaemia18 and 
hypertension19 and public health approaches such as policies to 
reduce tobacco exposure20 intended to reduce the risk of cardio-
vascular disease and to (ii) improvement in management of acute 
atherosclerotic disease including coronary revascularisation for 
ST elevation myocardial infarction21 and appropriate medical 
therapy for secondary prevention of cardiovascular disease 
including antiplatelet therapy, statins and ACE inhibitors.22 23
Studies have sought to evaluate the relative contributions of 
medical therapies and risk factors to cardiovascular trends over 
specific periods in several countries.24–26 The IMPACT model, 
which aims to quantify the contributions of temporal changes 
in exposure to risk factors and uptake of treatments to declines 
in IHD deaths, has estimated that in Scotland between 1975–
1994 medical treatment accounted for 40% of the reduction 
in IHD mortality, and wider risk factors 51%, while between 
2000–2010 they accounted for 43% and 39%, respectively.25 27 
Similar IMPACT analysis shows medical treatment contributed 
52% and risk factors 34% to IHD reductions in England over 
2000–2007 and to 42% and 58% of reductions in E&W over 
1981–2000.28 29 Inequalities in the risk factors for cardiovascular 
disease rather than medical treatment uptake, which appears to 
be uniformly delivered across deprivation groups in the IMPACT 
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model, could help explain the inequalities in IHD and CeVD in 
Scotland.17 27 29 Likewise risk factors such as increasing trends in 
body mass index and diabetes are likely to have diminished the 
reduction in IHD mortality rates in recent decades.27 30
Implications and conclusions
There have been substantial improvements in mortality in two 
of the leading causes of death in Scotland. CeVD mortality has 
improved steadily since the mid-1970s, while IHD mortality 
more rapidly since the mid-1980s. The trends in their mortality 
exhibit age but not distinct period or cohort effects. Mortality 
rates were higher, and inequalities greater, among males. 
Inequalities in IHD widened from the late 1980s until around 
2000, after which absolute inequalities decreased. Mortality 
from CeVD only became unequal from the late 1980s.
IHD and CeVD improvement has been important to the overall 
all-cause mortality improvement seen in Scotland. However, 
recent evidence sources show that this is now changing (Fenton 
et al, 2019, personal communication) and that it is imperative 
that we seek to understand the recent changes better to deter-
mine how we can improve mortality rates from these outcomes 
in order to impact on the overall Scottish mortality rate and 
prevent the current stalling in life expectancy.
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